DK3619199T3 - Fremstilling af 2-([1,2,3]triazol-2-yl)-benzoesyrederivater - Google Patents

Fremstilling af 2-([1,2,3]triazol-2-yl)-benzoesyrederivater Download PDF

Info

Publication number
DK3619199T3
DK3619199T3 DK18722948.9T DK18722948T DK3619199T3 DK 3619199 T3 DK3619199 T3 DK 3619199T3 DK 18722948 T DK18722948 T DK 18722948T DK 3619199 T3 DK3619199 T3 DK 3619199T3
Authority
DK
Denmark
Prior art keywords
triazol
preparation
benzoic acid
acid derivatives
derivatives
Prior art date
Application number
DK18722948.9T
Other languages
English (en)
Inventor
Patric Dörrwächter
Gunther Schmidt
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK3619199T3 publication Critical patent/DK3619199T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/061,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/70Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
    • B01J23/72Copper
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK18722948.9T 2017-05-03 2018-05-02 Fremstilling af 2-([1,2,3]triazol-2-yl)-benzoesyrederivater DK3619199T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2017060451 2017-05-03
PCT/EP2018/061172 WO2018202689A1 (en) 2017-05-03 2018-05-02 Preparation of 2-([1,2,3]triazol-2-yl)-benzoic acid derivatives

Publications (1)

Publication Number Publication Date
DK3619199T3 true DK3619199T3 (da) 2021-09-27

Family

ID=62116854

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18722948.9T DK3619199T3 (da) 2017-05-03 2018-05-02 Fremstilling af 2-([1,2,3]triazol-2-yl)-benzoesyrederivater

Country Status (20)

Country Link
US (1) US11124488B2 (da)
EP (1) EP3619199B1 (da)
JP (1) JP7182562B2 (da)
KR (1) KR102582197B1 (da)
CN (1) CN110612291B (da)
CA (1) CA3059394C (da)
CY (1) CY1124777T1 (da)
DK (1) DK3619199T3 (da)
ES (1) ES2892161T3 (da)
HR (1) HRP20211304T1 (da)
HU (1) HUE055904T2 (da)
IL (1) IL270274B (da)
LT (1) LT3619199T (da)
MX (1) MX2019012902A (da)
PL (1) PL3619199T3 (da)
PT (1) PT3619199T (da)
RS (1) RS62357B1 (da)
SI (1) SI3619199T1 (da)
TW (1) TWI756418B (da)
WO (1) WO2018202689A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3175369A1 (en) 2020-04-19 2021-10-28 Guy Braunstein Medical use of daridorexant
TW202400149A (zh) 2022-05-13 2024-01-01 瑞士商愛杜西亞製藥有限公司 經噻唑并芳基-甲基取代之環狀肼-n-甲醯胺衍生物

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007285371A1 (en) 2006-08-15 2008-02-21 Actelion Pharmaceuticals Ltd. Azetidine compounds as orexin receptor antagonists
DE602007009284D1 (de) 2006-09-29 2010-10-28 Actelion Pharmaceuticals Ltd 3-aza-bicycloä3.1.0ühexanderivate
PE20081229A1 (es) 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
AR064561A1 (es) 2006-12-28 2009-04-08 Actelion Pharmaceuticals Ltd Derivados de 2-aza-biciclo[3.1.0]hexano y su uso en la preparacion de un medicamento para el tratamiento de enfermedades relacionadas con disfunciones generales del sistema de la orexina.
JP2010526869A (ja) 2007-05-14 2010-08-05 アクテリオン ファーマシューティカルズ リミテッド 2−シクロプロピル−チアゾール誘導体
EP2150115B1 (en) 2007-05-23 2013-09-18 Merck Sharp & Dohme Corp. Cyclopropyl pyrrolidine orexin receptor antagonists
JP5847087B2 (ja) 2009-10-23 2016-01-20 ヤンセン ファーマシューティカ エヌ.ベー. オレキシン受容体調節因子としての縮合複素環式化合物
KR101859400B1 (ko) 2009-10-23 2018-05-18 얀센 파마슈티카 엔.브이. 오렉신 수용체 조절제로서의 이치환된 옥타하이드로피롤로[3,4-c]피롤
US9062044B2 (en) 2009-10-23 2015-06-23 Janssen Pharmaceutica Nv Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
US20130281465A1 (en) 2010-12-17 2013-10-24 Taisho Pharmaceutical Co., Ltd. Pyrazole derivative
WO2012085857A1 (en) 2010-12-22 2012-06-28 Actelion Pharmaceuticals Ltd 3,8-diaza-bicyclo[4.2.0]oct-3-yl amides
EP2680697B1 (en) 2011-03-03 2018-01-10 Merck Sharp & Dohme Corp. Process for the preparation of an orexin receptor antagonist
US9586962B2 (en) 2011-04-20 2017-03-07 Janssen Pharmaceutica Nv Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators
TW201315730A (zh) 2011-07-05 2013-04-16 大正製藥股份有限公司 甲基哌啶衍生物
WO2013050938A1 (en) * 2011-10-04 2013-04-11 Actelion Pharmaceuticals Ltd 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives
IN2014CN04127A (da) 2011-11-08 2015-07-10 Actelion Pharmaceuticals Ltd
US9441254B2 (en) 2012-05-09 2016-09-13 Merck Sharp & Dohme Corp. Process for the preparation of an intermediate for an orexin receptor antagonist
KR101689093B1 (ko) 2012-06-04 2016-12-22 액테리온 파마슈티칼 리미티드 벤즈이미다졸-프롤린 유도체
JP2014015452A (ja) 2012-06-15 2014-01-30 Taisho Pharmaceutical Co Ltd ピラゾール誘導体を含有する医薬
SG11201502493XA (en) * 2012-10-10 2015-04-29 Actelion Pharmaceuticals Ltd Orexin receptor antagonists which are [ortho bi (hetero )aryl]-[2-(meta bi (hetero )aryl)-pyrrolidin-1-yl]-methanone derivatives
JP2016510810A (ja) 2013-03-12 2016-04-11 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd オレキシン受容体アンタゴニストとしてのアゼチジンアミド誘導体
TW201444821A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代之哌啶化合物及其作為食慾素受體調節劑之用途
TW201444849A (zh) * 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
UA119151C2 (uk) 2013-12-03 2019-05-10 Ідорсія Фармасьютікалз Лтд КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
HUE035731T2 (hu) 2013-12-03 2018-05-28 Idorsia Pharmaceuticals Ltd (S)-(2-(6-klór-7-metil-1H-benzo[d]imidazol-2-il)-2-metilpirrolidin-1-il)(5-metoxi-2- (2H-l,2,3-triazol-2-il)fenil)metanon kristályos formája és alkalmazása orexin receptor antagonistaként
TR201815342T4 (tr) 2013-12-04 2018-11-21 Idorsia Pharmaceuticals Ltd Benzimidazol-prolin türevlerinin kullanımı.
TW201613891A (en) 2014-02-12 2016-04-16 Eolas Therapeutics Inc Substituted prolines / piperidines as orexin receptor antagonists
WO2016020403A1 (en) 2014-08-04 2016-02-11 Sandoz Ag Preparation of a benzoic acid derivative and its use for the preparation of suvorexant
CN104649983B (zh) * 2014-12-23 2018-01-23 广东东阳光药业有限公司 一种酸的制备方法
US10131653B2 (en) 2015-04-24 2018-11-20 Takeda Pharmaceutical Company Limited Heterocyclic compound

Also Published As

Publication number Publication date
IL270274B (en) 2022-08-01
CN110612291A (zh) 2019-12-24
ES2892161T3 (es) 2022-02-02
JP2020518573A (ja) 2020-06-25
MX2019012902A (es) 2019-12-16
IL270274A (da) 2019-12-31
CY1124777T1 (el) 2022-11-25
SI3619199T1 (sl) 2021-11-30
CN110612291B (zh) 2024-02-13
PL3619199T3 (pl) 2021-12-20
KR102582197B1 (ko) 2023-09-22
HUE055904T2 (hu) 2021-12-28
EP3619199A1 (en) 2020-03-11
TW201843144A (zh) 2018-12-16
TWI756418B (zh) 2022-03-01
EP3619199B1 (en) 2021-07-07
US20210114997A1 (en) 2021-04-22
KR20200003097A (ko) 2020-01-08
PT3619199T (pt) 2021-10-01
RS62357B1 (sr) 2021-10-29
JP7182562B2 (ja) 2022-12-02
CA3059394C (en) 2023-09-12
CA3059394A1 (en) 2018-11-08
US11124488B2 (en) 2021-09-21
WO2018202689A1 (en) 2018-11-08
HRP20211304T1 (hr) 2021-11-12
LT3619199T (lt) 2021-09-27

Similar Documents

Publication Publication Date Title
MA47125A (fr) Dérivés de pyrazole en tant qu'inhibiteurs de malt1
MA55194A (fr) Composés hétérocycliques en tant qu'immunomodulateurs
MA45189A (fr) Nouveaux dérivés hétérocycliques utiles en tant qu'inhibiteurs de shp2
MA46981A (fr) Dérivés de benzimidazole en tant qu'inhibiteurs de bromodomaine
CU20180001A7 (es) Derivados de oxopiridina sustituidos y procesos para su preparación
EP3402787A4 (en) PROCESSES FOR PREPARING 2,5-FURANDICARBOXYLIC ACID AND INTERMEDIATES AND DERIVATIVES THEREOF
MA40774A (fr) Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38
MA41140A (fr) Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg
DK3601225T3 (da) Substituerede indolinderivater som inhibitorer af denguevirus-replikation
MA42592A (fr) Utilisation de dérivés de 2-(pyrazolopyridin-3-yl) pyrimidine en tant qu'inhibiteurs de jak
DK3386991T3 (da) Polycykliske forbindelser som inhibitorer af bruton's tyrosinkinase
DK3279202T3 (da) Krystal af 3,5-disubstitueret benzenalkynylforbindelse
MA47736A (fr) Pyrimidopyrimidinones utiles en tant qu'inhibiteurs de la kinase wee-1
DK3390412T3 (da) Vandopløselige derivater af 3,5-diphenyl-diazolforbindelser
DK3277287T3 (da) Blandinger af humane mælke-oligosaccharider, der omfatter 3 '-o-sialyllactose
DK3823970T3 (da) Yderligere substituerede triazoloquinoxalinderivater
EP3490978A4 (en) SALTS OF 2, 6-DIMETHYLPYRIMIDONE DERIVATIVES AND THEIR USES
DK3823971T3 (da) Substituerede triazol-quinoxalin-derivater
DK3672977T3 (da) Boronsyrederivater
DK3619199T3 (da) Fremstilling af 2-([1,2,3]triazol-2-yl)-benzoesyrederivater
DK3589606T3 (da) Overgangsmetal-katalyseret protodecarboxylering af alfa-halo-akrylsyrederivater
DK3356329T3 (da) Fremgangsmåde til fremstilling af 1-(4-methansulfonyl-2-trifluormethylbenzyl)-2-methyl-1H-pyrrolo[2,3-B]pyridin-3-yleddikesyre
DK3515454T3 (da) Krystallinsk polymorf form af 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2lambda5-[1,2]oxaphosphinan
IL254578A0 (en) Abscisic acid (s)-2' vinyl derivatives
DK3398946T3 (da) Salt af morpholin-derivat og krystallin form deraf, samt fremstillingsfremgangsmåde, farmaceutisk sammensætning og anvendelse af samme